91ÖĆƬł§

Published on Market Research Reports® Inc. ()

Home > Asia Pacific Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity

Asia Pacific Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity

Publication ID: 
GRM0322020
Publication Date: 
March 31, 2022
Pages: 
139
Publisher: 
Grace Market Data
Countries: 
Asia Pacific [1]
USD 2,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Research & Development (Pharma & Healthcare) [2]
IT & eHealth [3]
Pharma & Healthcare [4]
Description: 

Asia Pacific pharmaceutical contract research organization (CRO) market will grow by 11.3% annually with a total addressable market cap of $ 212.8 billion over 2022-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.
Highlighted with 66 tables and 47 figures, this 139-page report “Asia Pacific Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific pharmaceutical contract research organization (CRO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2030 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific pharmaceutical contract research organization (CRO) market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country.

Based on Service, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
• CRO for Pre-clinical Development
• CRO for Phase I Trials
• CRO for Phase II Trials
• CRO for Phase III Trials
• CRO for Phase IV Trials
• Laboratory Services
• Consulting Services
• Data Management Services
Based on Therapeutic Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
• Infectious Diseases
• Oncology
• Metabolic Disorders
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Gastrointestinal Disorders
• Other Therapeutic Applications

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes

Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2021-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co., Ltd.
ICON Plc
IQVIA Holdings Inc.
LSK Asia Pacific Pharma Service Co., Ltd.
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co., Ltd.
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents: 

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 33
2.4 Emerging Opportunities and Market Trends 36
2.5 Porter’s Fiver Forces Analysis 40
3 Segmentation of Asia Pacific Market by Service 44
3.1 Market Overview by Service 44
3.2 CRO for Pre-clinical Development 46
3.3 CRO for Phase I Trials 47
3.4 CRO for Phase II Trials 48
3.5 CRO for Phase III Trials 49
3.6 CRO for Phase IV Trials 50
3.7 Laboratory Services 51
3.8 Consulting Services 52
3.9 Data Management Services 53
4 Segmentation of Asia Pacific Market by Therapeutic Application 54
4.1 Market Overview by Therapeutic Application 54
4.2 Infectious Diseases 56
4.3 Oncology 57
4.4 Metabolic Disorders 58
4.5 Cardiovascular Disorders 59
4.6 Central Nervous System 60
4.7 Respiratory Disorders 61
4.8 Gastrointestinal Disorders 62
4.9 Other Therapeutic Applications 63
5 Segmentation of Asia Pacific Market by End User 64
5.1 Market Overview by End User 64
5.2 Pharmaceutical & Biopharmaceutical Companies 66
5.3 Medical Device Companies 67
5.4 Academic Institutes 68
6 Asia-Pacific Market 2019-2030 by Country 69
6.1 Overview of Asia-Pacific Market 69
6.2 Japan 72
6.3 China 75
6.4 Australia 77
6.5 India 79
6.6 South Korea 82
6.7 Rest of APAC Region 84
7 Competitive Landscape 86
7.1 Overview of Key Vendors 86
7.2 New Product Launch, Partnership, Investment, and M&A 90
7.3 Company Profiles 91
Charles River Laboratories 91
CMIC Co. Ltd 93
Covance Inc. 95
Hangzhou Tigermed Consulting Co., Ltd. 99
ICON Plc 102
IQVIA Holdings Inc. 105
LSK Global Pharma Service Co., Ltd. 109
Novotech Pty Ltd 111
PAREXEL International Corporation 113
Pharmaceutical Product Development LLC (PPD) 117
PRA Health Sciences Inc. 119
Quanticate Ltd 121
Samsung Bioepis Co., Ltd. 123
SGS SA (SGS Life Sciences) 125
Syneos Health Inc. 128
WuXi AppTec Inc. 131
8 Investing in Asia Pacific Market: Risk Assessment and Management 133
8.1 Risk Evaluation of Asia Pacific Market 133
8.2 Critical Success Factors (CSFs) 136
Related Reports and Products 139

Companies Mentioned: 

Selected Key Players:
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co., Ltd.
ICON Plc
IQVIA Holdings Inc.
LSK Global Pharma Service Co., Ltd.
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co., Ltd.
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ěý

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ěý

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/grace-market-data/asia-pacific-pharmaceutical-contract-research-organization-cro-market-2021-2030

Links
[1] /countries/asia-pacific[2] /research-development-pharma-healthcare[3] /it-ehealth[4] /pharma-healthcare